78 Percent More Capital for German Biotech
Financing for companies in Germany rose markedly in 2024, with interest particularly strong in cancer treatments.
Your company is already operating in Germany and you would now like to export worldwide?
Search
Search results
-
Jan 17, 2025 Medical Biotechnologystore page page bookmarked
-
Sep 24, 2024 - Sep 24, 2024 Event London Medical Technologies
Exploring HealthTech Opportunities
Join the DACH Invest MedTech event and get the latest updates from the DACH countries.
This forum explores business opportunities in the largest and most important healthtech regions in Europe. -
May 06, 2024 Research and Developmentstore page page bookmarked
Merck to Build EUR 300-Million Research Center
The pharmaceuticals and chemicals giant is investing a hefty nine-figure in a state-of-the-art facility in its home city of Darmstadt.
-
Feb 21, 2024 Healthcare, Generalstore page page bookmarked
Life Science Healthcare News | February 2024
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
-
Jan 24, 2024 Pharmaceuticalsstore page page bookmarked
Germany Approves Diabetes Medication for Obesity
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
-
Jan 12, 2024 Medical Biotechnologystore page page bookmarked
Capital Increasing in German Biotech
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
-
Dec 14, 2023 Pharmaceuticalsstore page page bookmarked
Big Changes Coming in German Health, Pharma
Germany is undertaking a “digital revolution” in healthcare and now has a strategy to make life easier for pharmaceutical companies.
-
Oct 09, 2023 Healthcarestore page page bookmarked
Life Sciences - Healthcare News | October 2023
Innovative start-ups are booming in Germany's attractive life sciences sector.
-
Jul 26, 2023 FDIstore page page bookmarked
Takeda Invests Over EUR 300 Million in Vaccine Made in Germany
Japanese pharmaceuticals giant Takeda has put hundreds of millions of euros in recent years into its location in the southwestern German town of Singen to produce its anti-dengue-fever vaccine “Qdenga.”
-
Jul 18, 2023 Healthcarestore page page bookmarked
German Pharma Company Investments on the Rise
The mood in German pharmaceuticals is bright, with companies looking to increase investment.
